Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Neon Healthcare Limited, Mill Studio Business Centre, Crane Mead, Ware, Hertfordshire, SG12 9PY, United Kingdom
Suprecur Injection.
| Pharmaceutical Form |
|---|
|
Solution for Injection. |
Suprecur Injection contains 1.00mg buserelin as buserelin acetate in 1ml aqueous solution.
1.00mg buserelin is equivalent to 1.05mg buserelin acetate.
Suprecur Injection also contains 10mg benzyl alcohol in 1ml aqueous solution. For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Buserelin |
Buserelin is a synthetic peptide. It is a superactive analogue of natural gonadotrophin releasing hormone (gonadorelin, LHRH or GNRH). After an initial stimulation of gonadotrophin release, it down-regulates the hypothalanic-pituitary-gonadal axis. |
| List of Excipients |
|---|
|
Sodium chloride Ph.Eur. |
Box of 2 × 5.5 ml multidose vials each containing 1.05 mg buserelin acetate per 1 ml, corresponding to 1.00 mg buserelin per 1 ml.
Neon Healthcare Limited, Mill Studio Business Centre, Crane Mead, Ware, Hertfordshire, SG12 9PY, United Kingdom
PL 45043/0051
23 April 2002
| Drug | Countries | |
|---|---|---|
| SUPRECUR | Austria, Estonia, Japan, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
